Sobi - Swedish Orphan Biovitrum AB (publ) Company Contacts

Sobi - Swedish Orphan Biovitrum AB (publ)

http://www.sobi.com
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. We provide sustainable access to innovative therapies in the areas of haematology, immunology, and specialty indications. Today, we employ approximately 1,800 people across Europe, North... Read More
Contacts

Country

Sweden

City

Stockholm

Headquarters

Stockholm, SE

Profile

Industry

Pharmaceutical Manufacturing

Size

1001 - 5000

Specialties

orphan drugs, hereditary metabolic disorders, haemophilia, biopharmaceuticals, patient access, rare diseases, haematology, hematology, immunology, autoimmune

Funding

Total Rounds

2

Last Round

Tue May 07 2024

Last Round Series

Post IPO debt

Last Round Raised

$ 274,917,390